Impact of COVID-19 on the Economy and Overseas Procurement
First written in FY2020-Q3. 12 of 19 entries say "Restated". Latest entry: FY2026-H1.
Nishikawa Keisoku moved to the "Worse" side of this theme in 2021, 1 year after the typical company in this theme (2020).
The whole theme swung hardest in 2025: 5 of 16 companies on the "Worse" side.
19 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「During the interim accounting period, there were no new matters relating to the business or accounting information described in this interim report that could materially affect investment decisions, nor any material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」
The report states that there have been no material changes to existing risks, including the impact of COVID-19 on the economy and overseas procurement. - FY2025RestatedAnnual report
「During the fiscal year, Japan's economy saw substantial progress toward the normalization of social and economic activity as COVID-19 was reclassified as a Class 5 infectious disease,」
While describing the reclassification of COVID-19 as a Class 5 infectious disease and the normalization of social and economic activity, the report continues to identify the risks of large-scale disasters and the spread of infectious diseases, including COVID-19, together with related response measures, as key risks. - FY2025-H1RestatedAnnual report
「During the interim accounting period, there were no new matters relating to the business or accounting information described in this interim report that could materially affect investment decisions, nor any material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」
The report states that there have been no material changes to existing risks, including the impact of COVID-19 on the economy and overseas procurement. - FY2024MitigatedAnnual report
「During the fiscal year, Japan's economy recovered moderately as COVID-19 was reclassified as a Class 5 infectious disease, social and economic activity moved substantially toward normalization, employment and income conditions improved, and the Nikkei Stock Average reached a new record high.」
The report describes the reclassification of COVID-19 as a Class 5 infectious disease and the normalization of social and economic activity, indicating an improvement from the previous concerns over the spread of infection and declining capital investment. - FY2024-Q2RestatedAnnual report
「During the cumulative second-quarter period, there were no new matters relating to the business or accounting information described in this quarterly report that could materially affect investment decisions, nor any material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」
The report states that there have been no material changes to existing risks, including the impact of COVID-19 on the economy and overseas procurement. - FY2024-Q1RestatedAnnual report
「During the cumulative first-quarter period, there were no new matters relating to the business or accounting information described in this quarterly report that could materially affect investment decisions, nor any material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」
The report states that there have been no material changes to existing risks, including the impact of COVID-19 on the economy and overseas procurement. - FY2023MitigatedAnnual report
「During the fiscal year, Japan's economy showed signs of a gradual recovery as economic activity moved toward normalization following the gradual easing of restrictions on activities related to COVID-19.」
The report describes the easing of restrictions on activities related to COVID-19 and the normalization of economic activity, indicating an improvement from the previous concerns over the spread of infection and declining capital investment. - FY2023-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no new matters relating to the business or accounting information described in this quarterly report that could materially affect investment decisions, nor any material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」
The report states that there have been no material changes to existing risks, including the impact of COVID-19 on the economy and overseas procurement. - FY2023-Q2RestatedAnnual report
「During the cumulative second-quarter period, there were no new matters relating to the business or accounting information described in this quarterly report that could materially affect investment decisions, nor any material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」
The report states that there have been no material changes to existing risks, including the impact of COVID-19 on the economy and overseas procurement. - FY2023-Q1RestatedAnnual report
「During the cumulative first-quarter period, there were no new matters relating to the business or accounting information described in this quarterly report that could materially affect investment decisions, nor any material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」
The report states that there have been no material changes to existing risks, including the impact of COVID-19 on the economy and overseas procurement. - FY2022WorsenedAnnual report
「The timing of COVID-19 containment cannot be predicted accurately, and deterioration in the order environment is a concern, particularly in industries affected by the pandemic. However, the Company has determined that the impact on accounting estimates, including the recoverability of deferred tax assets, is limited.」
The report states that the timing of containment of the infection cannot be predicted accurately and that deterioration in the order environment is a concern, particularly in industries affected by the pandemic. - FY2022-Q2RestatedAnnual report
「There have been no material changes to the assumptions, including assumptions regarding the future spread of COVID-19 and the timing of its containment, described in the supplementary information to the securities report submitted for the previous fiscal year.」
The report states that there have been no material changes to the previous fiscal year's assumptions regarding the future spread of COVID-19 and the timing of its containment. - FY2022-Q1RestatedAnnual report
「There have been no material changes to the assumptions, including assumptions regarding the future spread of COVID-19 and the timing of its containment, described in the supplementary information to the securities report submitted for the previous fiscal year.」
The report states that there have been no material changes to the previous fiscal year's assumptions regarding the future spread of COVID-19 and the timing of its containment. - FY2021RestatedAnnual report
「As COVID-19 continued to spread globally, the global economy remained uncertain. If the spread of the infection causes customer companies' capital investment demand to decline substantially, this could affect the Company's performance.」
The report continues to identify uncertainty in the global economy caused by COVID-19 and the risk of lower capital investment demand. - FY2021-Q3WorsenedAnnual report
「During the cumulative third quarter period, Japan's economy remained in an uncertain position, as COVID-19 showed no signs of containment and the government issued two declarations of a state of emergency, raising concerns about sharp changes in economic activity and a renewed spread of infections.」
The report states that COVID-19 showed no signs of containment and that concerns continued regarding changes in economic activity caused by declarations of a state of emergency and a renewed spread of infections. - FY2021-Q2WorsenedAnnual report
「In terms of orders, overall capital investment demand declined as COVID-19 spread, while continued demand related to semiconductors and telecommunications kept orders broadly at the previous fiscal year's level. Orders were ¥15.319 billion, up 0.1% year on year.」
Overall capital investment demand continues to decline as COVID-19 spreads. However, demand related to semiconductors and telecommunications kept orders broadly at the previous fiscal year's level. - FY2021-Q1RestatedAnnual report
「There have been no material changes to the assumptions, including assumptions regarding the future spread of COVID-19 and the timing of its containment, described in the supplementary information to the securities report submitted for the previous fiscal year.」
The report states that there have been no material changes to the previous fiscal year's assumptions regarding the future spread of COVID-19 and the timing of its containment. - FY2020MaterialisedAnnual report
「In the Analytical Instruments (Laboratory Analyzers) segment, net sales were ¥6.606 billion, down 13.2% year on year, due in part to a decline in orders resulting from COVID-19 and postponements of construction schedules caused by restrictions on access to customer sites.」
The report states that the decline in orders due to COVID-19, restrictions on access to customer sites and construction schedule postponements affected actual performance. It also explicitly states that weak capital investment demand may persist for an extended period. - FY2020-Q3First statedAnnual report
「Under these operating conditions, equipment renewal projects related to lifelines, namely electricity, gas and water, remained solid. However, automotive-related projects and projects for the petroleum and chemical industries were sluggish, and delays in overseas procurement due to the impact of COVID-19 also affected operations. As a result, net sales were ¥24.837 billion, down 9.0% year on year.」
The report identifies delays in overseas procurement due to COVID-19 as an actual factor affecting performance, indicating that infectious disease risk materialized in procurement.